Ginette Serrero

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 10

Top Venues

Journal of cellular biochemistry

Cancers

Diagnostic pathology

PloS one

University of Maryland School of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Maryland School of Pharmacy

United States

Adjunct Professor :: Pharmaceutical Sciences

University of Maryland School of Pharmacy

United States

Professor :: Pharmaceutical Sciences

University of Maryland School of Pharmacy

United States

Associate Professor :: Pharmaceutical Sciences

Publications

Jorge Marquez, Jianping Dong, Jun Hayashi, Ginette Serrero
Prostaglandin F2 Receptor Negative Regulator (PTGFRN) Expression Correlates With a Metastatic-like Phenotype in Epidermoid Carcinoma, Pediatric Medulloblastoma, and Mesothelioma. Journal of cellular biochemistry (2024)
Jorge Marquez, Jianping Dong, Jun Hayashi, Ginette Serrero
Prostaglandin F2 Receptor Negative Regulator (PTGFRN) Expression Correlates With a Metastatic-like Phenotype in Epidermoid Carcinoma, Pediatric Medulloblastoma, and Mesothelioma. Journal of cellular biochemistry 125 (8) (2024)
Alexander Fichte, Angela Neumann, Katrin Weigelt, Juan Guzman, Thilo Jansen, Julia Keinert, Ginette Serrero, Binbin Yue, Robert Stöhr, Thomas Greither, Arndt Hartmann, Bernd Wullich, Helge Taubert, Sven Wach, Verena Lieb
Combined miR-486 and GP88 (Progranulin) Serum Levels Are Suggested as Supportive Biomarkers for Therapy Decision in Elderly Prostate Cancer Patients. Life (Basel, Switzerland) 12 (5) (2022)
Markus Eckstein, Verena Lieb, Rudolf Jung, Danijel Sikic, Katrin Weigelt, Robert Stöhr, Carol Geppert, Veronika Bahlinger, Simone Bertz, Ginette Serrero, Binbin Yue, Arndt Hartmann, Bernd Wullich, Helge Taubert, Sven Wach
Combination of GP88 Expression in Tumor Cells and Tumor-Infiltrating Immune Cells Is an Independent Prognostic Factor for Bladder Cancer Patients. Cells 10 (7) (2021)
Rupa Guha, Binbin Yue, Jianping Dong, Aditi Banerjee, Ginette Serrero
Anti-progranulin/GP88 antibody AG01 inhibits triple negative breast cancer cell proliferation and migration. Breast cancer research and treatment 186 (3) (2021)
Thomas Greither, Tina Steiner, Matthias Bache, Ginette Serrero, Sven Otto, Helge Taubert, Alexander W Eckert, Matthias Kappler
GP88/PGRN Serum Levels Are Associated with Prognosis for Oral Squamous Cell Carcinoma Patients. Biology 10 (5) (2021)
Jorge Marquez, Jianping Dong, Chun Dong, Changsheng Tian, Ginette Serrero
Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development. PloS one 16 (1) (2021)
Paul König, Markus Eckstein, Rudolf Jung, Amer Abdulrahman, Juan Guzman, Katrin Weigelt, Ginette Serrero, Jun Hayashi, Carol Geppert, Robert Stöhr, Arndt Hartmann, Bernd Wullich, Sven Wach, Helge Taubert, Verena Lieb
Expression of AR-V7 (Androgen Receptor Variant 7) Protein in Granular Cytoplasmic Structures Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers 12 (9) (2020)
Amer Abdulrahman, Markus Eckstein, Rudolf Jung, Juan Guzman, Katrin Weigelt, Ginette Serrero, Binbin Yue, Carol Geppert, Robert Stöhr, Arndt Hartmann, Bernd Wullich, Sven Wach, Helge Taubert, Verena Lieb
Expression of GP88 (Progranulin) Protein Is an Independent Prognostic Factor in Prostate Cancer Patients. Cancers 11 (12) (2019)
Ginette Serrero, Douglas M Hawkins, Pablo A Bejarano, Olga Ioffe, Katherine R Tkaczuk, Robert E Elliott, Jonathan F Head, Jeffrey Phillips, Andrew K Godwin, JoEllen Weaver, David Hicks, Binbin Yue
Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index. Diagnostic pathology 11 (1) (2016)

Ginette Serrero.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ginette Serrero